Benjamin J. Hindson, See Remarks at 10x Genomics, Inc. (TXG), sold 77,620 shares at $160.50 ($12.7M) on 2021-11-01, disclosed to the SEC on 2021-11-03.
Open-market sale of $12.7M TXG by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $160.50 | 1,100 | $177K | 1.4% |
| 2 | $162.06 | 1,500 | $243K | 1.9% |
| 3 | $163.15 | 11,829 | $1.9M | 15.2% |
| 4 | $163.15 | 11,829 | $1.9M | 15.2% |
| 5 | $163.87 | 24,125 | $4.0M | 31.1% |
| 6 | $163.87 | 24,125 |
| $4.0M |
| 31.1% |
| 7 | $164.75 | 3,112 | $513K | 4.0% |
| Total | $163.60 avg | 77,620 | $12.7M | 100% |
| Filing → |
| TXG | SELL | 2026-02-25 | $145K | — | Filing → |
| TXG | SELL | 2025-11-25 | $157K | — | Filing → |
| TXG | SELL | 2025-08-26 | $206K | — | Filing → |